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Today many potent anticancer drugs like cisplatin are available which carry a number of side effects.
A promising way of reducing the side effects is to target the drug to tissue sites by coating it with
biocompatible materials like Poly dl-lactide-co-glycolide PLGA polymer where controlled drug
release is achieved during the biodegradation of the polymer. Also the efficacy of anticancer drugs
like cisplatin increases at elevated temperatures, so if local heating can be achieved where the drug
is targeted. Local heating can be achieved by introducing iron core nanoparticles in the composites
along with the drug, which can be heated by the 2.4 GHz microwaves. Local heating of the
nanocomposites also helps to swell the polymer shell and enhance the drug release. The magnetic
nanocomposites were synthesized using iron nanoparticles, PLGA and a fluorescent dye,
tris-2,2bipyridyl dichlororuthenium II using an oil-in-emulsion technique. The emulsion
contains PLGA, dye, and iron nanoparticles dissolved in the oil phase and polyvinyl alcohol PVA
as a stabilizer. As the sample is homogenized, and dried, uniform 100 nm composites are formed
where the dye and iron nanoparticles are encapsulated in a PLGA shell. Control of the thickness and
loading efficiency of the nanocomposite can be controlled by varying the ratio of PLGA, iron, and
dye. The amount of loading was determined using TGA confirming from 20–50% w/w loading. As
the dye is released from the composite the fluorescence intensity decreases due to self-quenching.
This self-quenching allows for the determination of the release kinetics as a function of temperature
using fluorescence spectroscopy. Initial results suggest that there is a release of 5–10% of the dye
from the composite at 25°C and complete release after the nanocomposite reaches 90°C. Using
local microwave heating the complete release of the dye can be accomplished with three two second
pulses of 2.4 GHz microwaves. This allows for the complete drug delivery platform which allows
for the controlled release using microwave frequency. © 2008 American Institute of Physics.
DOI: 10.1063/1.2836795
INTRODUCTION
Pharmaceutical research today is more concentrated on
drug delivery systems rather than new drug discovery. An
ideal drug delivery system would be one that can target the
drug or release of the drug in a specific region, thereby re-
ducing the drug’s toxicity and enhancing the drug efficacy.
An effective way of achieving these goals is by creating a
composite containing the drug with biocompatible polymers
and magnetic nanoparticles.1,2 Polyesters such as polyD,L-
lactide-co-glycolide PLGA, polyD,L-lactide PLA, and
polyglycolide PGA are approved by the FDA due to their
biocompatibility, biodegradability, and lower toxicity. The
encapsulation of the drug of interest in the desired biocom-
patible polymer can be achieved by oil-in-water emulsion
techniques yielding microsized composites.3 In these cases,
through irradiation of a region with microwave radiation, the
magnetic nanoparticles cause the polymer to swell, thus, re-
leasing the drug in the given region. This has the additional
advantage of increasing the efficacy of some anticancer
drugs increasing at elevated temperatures.4–6 Although the
2.45 GHz microwave radiation also heats water, the nanopar-
ticles absorb far more of the radiation heating faster creating
a localized heating effect around the composite.
II. EXPERIMENTAL AND CHARACTERIZATION
The PLGA coated magnetic microcomposites were pre-
pared using magnetic iron core nanoparticles, PLGA, and
fluorescent dye-tris-2,2bipyridyl dichlororuthenium II
Rubpy3Cl2 ·6H2O as the drug mimic by oil-in-water
emulsion technique.7,8 Tris-2,2bipyridyl dichlororuthe-
nium II was used as the drug mimic because it is a metal
complex based fluorescent dye that can be quenched by iron
oxide. PolyD,L-lactide-co-glycolide 50:50i.v PLGA was
obtained from Polysciences, Inc. Polyvinyl alcohol 88%
hydrolyzed with an average molecular weight of 88 000 and
anhydrous dichloromethane DCM were purchased from Ar-
cos organics. Tris-2,2bipyridyl dichlororuthenium II
Rubpy3Cl2 ·6H2O was purchased from Sigma Aldrich.
All chemicals were used as received without further purifi-
cation.
The iron-iron oxide core-shell nanoparticles were syn-
thesized via reverse micelles under nitrogen using Schlenk
line techniques as found in the literature.9,10 A schematic
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representation of the encapsulation process is shown in Fig.
1. As shown in the figure, the as synthesized iron-iron oxide
core-shell nanoparticles were dispersed in 0.5M NaOH and
then treated with equivalent grams of sorbitol and sonicated
for 4 h. Sorbitol was used to provide a negatively charged
particle surface to which the ruthenium dye could easily
adhere. The sorbitol treated nanoparticles were then mag-
netically separated and 50 mg of ruthenium dye
Rubpy3Cl2 ·6H2O in 2 ml of water was added. This was
further sonicated for 4 h and freeze dried to obtain the
nanoparticle-dye mixture. Then, 2 wt % of PLGA in DCM
polymer solution was prepared and 50 mg of the
nanoparticle-dye mixture was then added and sonicated for
5 min. This organic mixture oil phase was then mixed with
50 ml of aqueous phase containing 3.8% w /v polyvinyl al-
cohol solution and homogenized with Ultra Turrax IKA
T-18 basic homogenizer at 22 000 rpm for 5 min. Then,
100 ml distilled water was added to the oil-in-water emul-
sion, which dilutes the organic solvent concentration in water
and leads to the hardening of the microcomposites. The so-
lution was stirred overnight to evaporate the organic solvent
and then freeze dried. The loading efficiency and the thick-
ness of the PLGA coating can be controlled by varying the
ratios of PLGA, iron nanoparticles, and the fluorescent dye.
The size distribution and the morphology of the prepared
microcomposites were determined using a scanning electron
microscope SEM with a Zeiss EVO 50 Carl Zeiss, Inc.
The core-shell morphology and size of the nanoparticles
were determined by transmission electron microscope
TEM with a Joel JEM-1230 Joel Ltd. The loading effi-
ciency of the iron nanoparticles and the dye, and the release
rate of the dye were determined by fluorescence spectros-
copy and thermogravimetric analysis TGA.
DISCUSSION
SEM was performed to determine the size distribution
and the morphology of the prepared microcomposites. Figure
2 shows the SEM image of the magnetic PLGA microcom-
posites which are roughly around 200 nm–1.5 m in size
and show fairly spherical structure. The inset shows the TEM
image of the iron nanoparticles which illustrates the core-
shell structure of the particles with an average particle size of
15 nm. The size distribution of the microcomposites is attrib-
uted to the oil-in-water droplet formation and the solvent
evaporation from the polymer solvent interface. There are
other factors such as the duration of sonication and homog-
enization, the speed of homogenizer, etc., which affect the
size of the microcomposites formed.8 In general, longer
sonication/homogenization times and higher speed of the ho-
mogenizer which produces high shear induced by the ho-
mogenizer blade, thus, leading to smaller particle size. Too
much loading of the ruthenium dye leads to a loss of mor-
phological control and the composites turn into irregular
shapes. It can be speculated that the ruthenium dye could
precipitate in due to lack of water during the nanoparticle-
dye mixture preparation. The particle size of the precipitated
dye could be bigger than the oil-in-water bubbles formed,
thus, disturbing the droplet formation. The other speculation
would be that as the dye content is increased, more dye is
likely to disperse in the aqueous phase, thus, disturbing the
droplet formation.
The loading efficiency of the prepared magnetic PLGA
microcomposites was determined using TGA and fluores-
cence spectroscopy. A 5 mg of the microcomposite was dis-
solved in dichloromethane. The iron nanoparticles and the
ruthenium dye fall out in the organic solution. Known vol-
ume of water was added to the organic solution to extract the
dye in the water. Fluorescence measurements were per-
formed on the water layer to determine the dye content in
5 mg of the composites. Fluorescence intensity of known
concentration of ruthenium dye was measured and a linear
curve fit was performed which yields around 0.25% w /w
fluorescent dye loading in the microcomposites. Attempts
were made to improve the loading efficiency of the dye but it
leads to the loss of the spherical morphology of the compos-
ites, as discussed earlier. TGA results also confirmed the per-
centage dye loading and shows approximately 40% w /w iron
nanoparticles loading in the composite. TGA results com-
bined with theoretical calculations based on the volume-
density resulted into approximately 4000 iron nanoparticles
embedded into roughly 500 nm composite. However, this
leads to the loss of morphology control, as discussed previ-
ously.
Fluorescence spectroscopy was performed to study the
release kinetics of the dye. As the dye is released from the
FIG. 1. Schematic representation of PLGA encapsulation of iron nanopar-
ticles and fluorescent dye.
FIG. 2. Color online SEM image of the magnetic PLGA microcomposites.
The inset shows the TEM image of the iron core-shell nanoparticles.
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composite, the fluorescence intensity decreases due to the
quenching of the ruthenium dye by the iron nanoparticles
which allows for the determination of the release kinetics as
a function of temperature. The composites were dispersed in
water and heated with 2.45 GHz microwave by irradiating
with a pulse of 1 s duration each utilizing a laboratory mi-
crowave unit. To achieve uniform heating of the composite
sample and water as the reference, the turntable within the
microwave unit was removed and the composite sample and
water were heated from one to five times with a pulse of 1 s
duration each. The iron nanoparticles encapsulated within the
composite absorb the microwaves and heat up providing lo-
cal heating. This also swells up the polymer coating and
leads to the release of the dye. The bulk water temperature of
the composite sample as well as the reference reached up to
32 °C after irradiating the sample five times with a pulse of
1 s duration each. Fluorescent measurements were carried
out after irradiating the sample for one to five times with 1 s
pulse each, as well as heating the sample to 30, 40, and
50 °C. The sample was just heated five times as further heat-
ing leads to increase in the temperature drastically. Figure 3.
shows the plot of the fluorescence intensity with time of
irradiation of the sample by the microwaves. The horizontal
lines on the plot corresponds to the fluorescence intensity of
the sample when heated externally up to 30, 40, and 50 °C.
It can be seen that the rate of release of the dye at 2 s is equal
to that of 30 °C and the 4 s irradiation release equals to
40 °C. Thus, we were able to achieve higher dye release by
locally heating the sample with 2 GHz microwave pulse
compared to externally heating the composite sample. Heat-
ing the composites five times with 1 s pulse each did not
elevate the temperature above 32 °C but the composite ex-
perienced a temperature rise roughly at about 50 °C with
higher release of the dye.
CONCLUSION
The magnetic PLGA microcomposites prepared showed
enhanced dye release when irradiated with 2.45 GHz micro-
waves. The composite when heated by the pulsed micro-
waves experienced a temperature rise of 32 °C while show-
ing a drug release at roughly about 50 °C. The magnetic
PLGA microcomposites thus show the potential of being the
ideal drug delivery system for cancer treatment.
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FIG. 3. Plot of fluorescence intensity vs time. The horizontal lines shows the
fluorescent intensity at room temperature 22 °C, 30, 40, and 50 °C tem-
perature as measured by fluorescence spectrometer.
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